Ironwood Pharma (IRWD) Tops Q4 EPS by 4c

Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $94.2 thousand versus the consensus estimate of $86.2 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance